PT83792B - Cadn superoxido de manganesio-dismutase humana, sua expressao em bacterias e metodo para o seu isolamento sob uma forma enzimaticamente activa - Google Patents

Cadn superoxido de manganesio-dismutase humana, sua expressao em bacterias e metodo para o seu isolamento sob uma forma enzimaticamente activa

Info

Publication number
PT83792B
PT83792B PT83792A PT8379286A PT83792B PT 83792 B PT83792 B PT 83792B PT 83792 A PT83792 A PT 83792A PT 8379286 A PT8379286 A PT 8379286A PT 83792 B PT83792 B PT 83792B
Authority
PT
Portugal
Prior art keywords
cadnus
bacteria
insulation
expression
active form
Prior art date
Application number
PT83792A
Other languages
English (en)
Portuguese (pt)
Other versions
PT83792A (en
Inventor
Jacob R Hartman
Yaffa Beck
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of PT83792A publication Critical patent/PT83792A/pt
Publication of PT83792B publication Critical patent/PT83792B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT83792A 1985-11-22 1986-11-21 Cadn superoxido de manganesio-dismutase humana, sua expressao em bacterias e metodo para o seu isolamento sob uma forma enzimaticamente activa PT83792B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (2)

Publication Number Publication Date
PT83792A PT83792A (en) 1986-12-01
PT83792B true PT83792B (pt) 1989-01-17

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83792A PT83792B (pt) 1985-11-22 1986-11-21 Cadn superoxido de manganesio-dismutase humana, sua expressao em bacterias e metodo para o seu isolamento sob uma forma enzimaticamente activa

Country Status (21)

Country Link
JP (2) JP2609449B2 (enrdf_load_stackoverflow)
AT (1) AT400443B (enrdf_load_stackoverflow)
AU (1) AU607897B2 (enrdf_load_stackoverflow)
BE (1) BE905796A (enrdf_load_stackoverflow)
CA (1) CA1341362C (enrdf_load_stackoverflow)
CH (1) CH676990A5 (enrdf_load_stackoverflow)
DE (1) DE3639725C2 (enrdf_load_stackoverflow)
DK (1) DK534686A (enrdf_load_stackoverflow)
ES (1) ES2003518A6 (enrdf_load_stackoverflow)
FI (1) FI90353C (enrdf_load_stackoverflow)
FR (1) FR2590591B1 (enrdf_load_stackoverflow)
GB (1) GB2183658B (enrdf_load_stackoverflow)
GR (1) GR862713B (enrdf_load_stackoverflow)
HK (1) HK75195A (enrdf_load_stackoverflow)
IE (1) IE59498B1 (enrdf_load_stackoverflow)
IL (2) IL106449A (enrdf_load_stackoverflow)
IT (1) IT1205418B (enrdf_load_stackoverflow)
LU (1) LU86676A1 (enrdf_load_stackoverflow)
NL (1) NL8602960A (enrdf_load_stackoverflow)
PT (1) PT83792B (enrdf_load_stackoverflow)
SE (1) SE8604884L (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
ATE132902T1 (de) * 1987-03-14 1996-01-15 Boehringer Ingelheim Int Humane mangan-superoxiddismutase (hmn-sod)
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
DE3854678T2 (de) * 1987-03-27 1996-06-13 Bio Technology General Corp Menschliches Mangansuperoxiddismutase und Behandlungsverfahren.
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
DK0587055T3 (da) * 1992-09-09 2002-04-02 Bio Technology General Corp Anvendelse af mangan-superoxiddismutase (Mn-SOD) til fremstilling af lægemidler til behandling af sygdomme i lav dosering
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
WO2025178510A1 (ru) * 2024-02-21 2025-08-28 Евгений Владимирович ГРИГОРЬЕВ Способ применения супероксиддисмутазы 2 в качестве антиоксиданта в сверхмалых дозировках

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
EP0138111B1 (en) * 1983-10-03 1991-11-21 Chiron Corporation Superoxide dismutase cloning and expression in microorganisms

Also Published As

Publication number Publication date
IE862851L (en) 1987-05-22
IT1205418B (it) 1989-03-15
CH676990A5 (enrdf_load_stackoverflow) 1991-03-28
DE3639725C2 (de) 1998-02-19
DE3639725A1 (de) 1987-07-23
FI864756A7 (fi) 1987-05-23
IL106449A (en) 1997-02-18
GB8627294D0 (en) 1986-12-17
AT400443B (de) 1995-12-27
DK534686D0 (da) 1986-11-07
JPS62289187A (ja) 1987-12-16
FI90353B (fi) 1993-10-15
GR862713B (en) 1987-03-24
ES2003518A6 (es) 1988-11-01
SE8604884D0 (sv) 1986-11-14
ATA308986A (de) 1995-05-15
JPH08289792A (ja) 1996-11-05
IT8667865A0 (it) 1986-11-21
DK534686A (da) 1987-05-23
BE905796A (fr) 1987-03-16
IE59498B1 (en) 1994-03-09
CA1341362C (en) 2002-05-28
FI864756A0 (fi) 1986-11-21
HK75195A (en) 1995-05-26
IL106449A0 (en) 1993-11-15
PT83792A (en) 1986-12-01
JP2609449B2 (ja) 1997-05-14
AU607897B2 (en) 1991-03-21
AU6497586A (en) 1987-05-28
NL8602960A (nl) 1987-06-16
LU86676A1 (fr) 1987-05-04
FI90353C (fi) 1994-01-25
GB2183658A (en) 1987-06-10
IL80702A0 (en) 1987-02-27
GB2183658B (en) 1990-04-25
SE8604884L (sv) 1987-05-23
JP2967557B2 (ja) 1999-10-25
FR2590591A1 (fr) 1987-05-29
FR2590591B1 (fr) 1989-12-01

Similar Documents

Publication Publication Date Title
PT83792B (pt) Cadn superoxido de manganesio-dismutase humana, sua expressao em bacterias e metodo para o seu isolamento sob uma forma enzimaticamente activa
FR2630546B1 (fr) Electrode enzymatique et son procede de preparation
KR880700691A (ko) 엘라스토머 ptfe 조성물, 제품 및 제조 방법
PT83037B (pt) Embalagem para comprimidos e seu metodo de utilizacao
FR2576220B1 (fr) Procede et di
BR8502688A (pt) Granulo contendo substancia fisiologicamente ativa,processo para preparar o mesmo e processo para criar ruminantes
BR8903449A (pt) Transistor bipolar,metodo para sua fabricacao e estrutura de transistor bipolar
FI881217A7 (fi) Menetelmiä auringon vahingoittaman ihmisihon hoitoon retinoideilla
DE3677115D1 (de) Zusammengesetzter ionenaustauscher und seine herstellung.
BR8700880A (pt) Derivados de glicolurila e sua aplicacao como estabilizadores de polimeros
FR2573981B1 (fr) Gel dentifrice et son procede de preparation
IT8319490A0 (it) S-adenosil metionina in cellule microbiche contenenti concentrazione elevata eprocedimento per la produzione di s-adenosil metionina.
NO862570D0 (no) Forbedret kollagenpoelseskinn.
DE3673587D1 (de) Magnetronanode und deren herstellung.
MX162282A (es) Mejoras en metodo para construir una estructura de aislamiento y estructura resultante
BR8600570A (pt) Processo para fazer pilha eletroquimica e respectiva pilha
DE3668366D1 (de) Manschettenverbindung und deren herstellungsverfahren.
DE3688168D1 (de) Epidermiszellenextrakte und verfahren zur verbesserung der wundheilung und zur regenerierung der epidermis.
BR8606551A (pt) Chumacos absorventes e metodo de producao
FR2579599B1 (fr) Substance physiologiquement active tpi et procede de preparation
BR8601155A (pt) Composicao anaerobicamente curavel
DE3687377D1 (de) Vitamin-d-abkoemmlinge und deren herstellungsverfahren.
FR2553411B1 (fr) Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
DE3581505D1 (de) Differenzierung menschlicher zellen.
FR2585566B1 (fr) Gel depilatoire transparent et son procede de preparation

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031231